Neo Ivy Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
+60,405
New +$1.55M 0.41% 95
2024
Q4
– Sell
-11,968
Closed -$758K – 259
2024
Q3
$758K Buy
+11,968
New +$864K 0.25% 152
2023
Q4
$1K Buy
+13
New +$962 ﹤0.01% 265
2022
Q4
$109K Buy
1,326
+1,257
+1,822% +$104K 0.07% 258
2022
Q3
$5K Buy
+69
New +$5.51K 0.01% 343
2021
Q4
– Sell
-1,412
Closed -$35K – 419
2021
Q3
$35K Buy
+1,412
New +$89.1K 0.04% 358
2021
Q2
– Sell
-6,514
Closed -$372K – 426
2021
Q1
$372K Buy
+6,514
New +$352K 0.41% 78
2020
Q3
– Sell
-1,412
Closed -$35K – 449
2020
Q2
$35K Buy
+1,412
New +$35.2K 0.04% 358
2020
Q1
– Sell
-131
Closed -$4K – 448
2019
Q4
$4K Buy
+131
New +$4.11K ﹤0.01% 240

Other funds holding ACHC

Neo Ivy Capital Management's ACHC Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 60,405 shares worth $1.78M. The stake represents 0.41% of the portfolio and ranks #95 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in ACHC as recently as Q3 2024.

Neo Ivy Capital Management first reported a position in ACHC in Q4 2019 and has held it in 9 quarters since. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Neo Ivy Capital Management held 60,405 shares of Acadia Healthcare worth $1.78M as of Q2 2026.
  • Acadia Healthcare was a new Neo Ivy Capital Management position in Q2 2026.
  • Acadia Healthcare made up 0.41% of Neo Ivy Capital Management's portfolio in Q2 2026, its #95 holding.
  • Neo Ivy Capital Management first reported a position in Acadia Healthcare in Q4 2019 and has held it in 9 quarters since.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.